Clinical Trials Browser

Interventional × ibritumomab tiuxetan × 1 year × Clear all

NCT00690560 2025-09-30

Combination Chemotherapy, Rituximab, and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Newly Diagnosed Large B-Cell Lymphoma

Phase 2 Completed

Lymphoma, Lymphoma, Large B-Cell, Diffuse

NCT01359592 2025-06-17

S1001 PET-Directed Therapy in Treating Patients With Limited-Stage Diffuse Large B-Cell Lymphoma

Phase 2 Completed

159 enrolled 21 charts

Lymphoma, Lymphoma, Large B-Cell, Diffuse